Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder ; day:4 ; month:10 ; year:2017 ; pages:1-16
CNS drugs ; (4.10.2017), 1-16
- Schlagwort
-
Biopharmazie
Pharmakodynamik
Pharmakokinetik
- Urheber
-
Newcorn, Jeffrey H.
- Beteiligte Personen und Organisationen
-
Nagy, Péter
Childress, Ann C.
Frick, Glen
Yan, Brian
Pliszka, Steven
SpringerLink (Online service)
- DOI
-
10.1007/s40263-017-0468-2
- URN
-
urn:nbn:de:1111-2017112810053
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.22025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Newcorn, Jeffrey H.
- Nagy, Péter
- Childress, Ann C.
- Frick, Glen
- Yan, Brian
- Pliszka, Steven
- SpringerLink (Online service)
Ähnliche Objekte (12)
Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case report
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case report
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR®) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: A pilot randomized placebo-controlled trial
Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
Pharmacogenetics of methylphenidate in childhood attention-deficit/hyperactivity disorder: long-term effects
High dose methylphenidate treatment in adult attention deficit hyperactivity disorder: a case report
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study